Video

Helping Patients Manage High Medication Co-pays

Author(s):

Lauren Santye, Assistant Editor

Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.

Deborah Michaelson, MS, RPh, vice president of Operations at Ardon Health, discusses how pharmacies can help patients overcome the cost of high co-pays to maintain specialty drug adherence.

Related Videos
Genetic engineering and gene manipulation concept. Hand is replacing part of a DNA molecule - Image credit: vchalup | stock.adobe.com
Related Content
Precision medicine in neurology -- Image credit: Evon J | stock.adobe.com
April 9th 2025

AAN 2025: Precision Medicine and Pharmacogenomics in Neurological Care

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Syringe and vial labeled GLP 1 are prominently displayed, symbolizing medical advancements and treatments. background features blurred, colorful pattern, enhancing focus on medical items - Image credit: mingnimit | stock.adobe.com
April 9th 2025

Expert Q&A: Exploring the Role of GLP-1 Receptor Agonists in Diabetes Management

Kennedy Ferruggia, Assistant Editor Elaina Rosario, PharmD, CPh, BCACP, CDCES
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Platelets forming a blood clot, AI Generative
April 4th 2025

Fitusiran Maintains Long-Term Bleeding Control in Hemophilia A or B, With or Without Inhibitors

Luke Halpern, Assistant Editor
FDA headquarters sign -- Image credit: JHVEPhoto | stock.adobe.com
April 3rd 2025

FDA Approves Inebilizumab to Treat Adult Patients With IgG4-RD

Gillian McGovern, Associate Editor